• OPEN AN ACCOUNT
Indian Indices
Sensex
72,382.47 472.77
( 0.66%)
Global Indices
Nasdaq
51,190.24 242.68
(0.48%)
Dow Jones
7,742.36 54.91
(0.71%)
Hang Seng
69,916.07 1,606.61
(2.35%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
96.17 0.25
(0.26%)
EUR-INR
108.49 -0.30
(-0.28%)
GBP-INR
127.16 -0.03
(-0.02%)
JPY-INR
0.61 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
44.84
86.16
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

sunrise industrial traders ltd
Titan Biotech consolidated net profit rises 66.17% in the March 2026 quarter
Jun 02,2026
Net profit of Titan Biotech rose 66.17% to Rs 6.73 crore in the quarter ended March 2026 as against Rs 4.05 crore during the previous quarter ended March 2025. Sales rose 38.84% to Rs 48.83 crore in the quarter ended March 2026 as against Rs 35.17 crore during the previous quarter ended March 2025.

For the full year,net profit rose 38.83% to Rs 29.89 crore in the year ended March 2026 as against Rs 21.53 crore during the previous year ended March 2025. Sales rose 31.79% to Rs 206.19 crore in the year ended March 2026 as against Rs 156.45 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales48.8335.17 39 206.19156.45 32
OPM %19.8912.99 -18.7216.25 -
PBDT11.585.87 97 43.1028.54 51
PBT10.285.03 104 38.1724.37 57
NP6.734.05 66 29.8921.53 39